Friday the 13th has turned into a horror story for Australian biotech Immutep, whose share price collapsed after it abandoned a pivotal trial of its lead drug. Immutep's ASX-listed stock fell more ...
They may look harmless, but they're certainly capable of turning your spreadsheets into traffic jams.
Explore the staff augmentation market in Southeast Asia and discover what Singapore businesses need to know about talent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results